Research Blog

Peptides Comparison BPC-157

BPC-157 vs TB-500: Research Peptide Comparison

BPC-157 and TB-500 are the two most widely researched repair peptides. Their mechanisms are complementary rather than competing, making them a common combination in recovery-focused research protocols.

12 Mar 2026 · 5 min read

Peptides Skin Tissue Repair

GHK-Cu: Copper Peptide Tissue Repair and Anti-Ageing Research

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is an endogenous tripeptide-copper complex with documented effects on wound healing, collagen synthesis, and gene expression. Extensive research spans dermatology, tissue repair, and anti-ageing applications.

10 Mar 2026 · 6 min read

SARMs Comparison Ostarine

Ostarine vs LGD-4033: Comparing Mild and Potent SARMs

Ostarine and LGD-4033 are both well-studied SARMs with published human trial data. This comparison examines their potency difference, suppression profiles, and how researchers typically approach each.

08 Mar 2026 · 4 min read

Peptides IGF-1 Growth Factor

IGF-1 LR3: Long-Acting Insulin-Like Growth Factor Research

IGF-1 LR3 is a recombinant analogue of IGF-1 with reduced IGFBP binding and extended half-life. It is a critical tool in research examining muscle hypertrophy, cellular proliferation, and GH axis downstream signalling.

07 Mar 2026 · 7 min read

Peptides Growth Hormone GHRH

Tesamorelin: FDA-Approved GHRH Analogue for Lipodystrophy Research

Tesamorelin (Egrifta) is a stabilised GHRH analogue with FDA approval for HIV-associated lipodystrophy. Its robust Phase III clinical dataset and specific visceral adiposity targeting make it uniquely valuable in metabolic research.

04 Mar 2026 · 6 min read

SARMs Comparison RAD-140

RAD-140 vs LGD-4033: Research Comparison

RAD-140 and LGD-4033 are the two most extensively researched potent SARMs. This article compares their mechanisms, published trial data, potency, suppression characteristics, and typical research applications.

04 Mar 2026 · 5 min read

Peptides Growth Hormone GHRH

Sermorelin: GHRH(1-29) and Growth Hormone Axis Research

Sermorelin is the synthetic form of GHRH 1-29, the biologically active N-terminal fragment of growth hormone releasing hormone. It was FDA-approved as a diagnostic agent and has an extensive clinical dataset from GH deficiency treatment studies.

01 Mar 2026 · 6 min read

SARMs YK-11 Myostatin

YK-11: Myostatin Inhibitor Research Compound Profile

YK-11 is a steroidal SARM with a unique dual mechanism — partial AR agonism combined with myostatin inhibition via Follistatin upregulation. This profile covers what the limited research shows.

28 Feb 2026 · 4 min read

Peptides Nootropic Neuroprotection

Semax: ACTH-Derived Neuroprotective and Nootropic Research

Semax is a synthetic heptapeptide derived from the ACTH 4-7 fragment. Extensive Russian clinical and preclinical research has characterised neuroprotective, cognitive-enhancing, and stroke-relevant effects, with registration as a pharmaceutical in Russia.

26 Feb 2026 · 6 min read

Peptides BPC-157 Recovery

BPC-157: Healing Peptide Research Compound Profile

BPC-157 is a synthetic pentadecapeptide derived from a gastric protein. Extensive rodent research documents accelerated healing of tendons, ligaments, bone, and GI tissue. This profile covers mechanism, preclinical data, and available forms.

24 Feb 2026 · 5 min read

Peptides Nootropic Anxiolytic

Selank: Anxiolytic and Nootropic Peptide Research Overview

Selank is a synthetic heptapeptide based on the endogenous immunomodulatory peptide tuftsin. Russian preclinical and clinical research has characterised anxiolytic, nootropic, and immunomodulatory effects across multiple studies.

23 Feb 2026 · 6 min read

Peptides Melanocortin MC4R

PT-141 (Bremelanotide): Melanocortin Agonist Sexual Function Research

PT-141, now approved as bremelanotide (Vyleesi), was derived from the Melanotan II programme. It has completed Phase III trials and achieved FDA approval for hypoactive sexual desire disorder, making it the most clinically validated peptide in the melanocortin research class.

20 Feb 2026 · 6 min read